Breaking News

Bicycle Therapeutics Ltd (BCYC)

NASDAQ

Add to/Remove from a Portfolio Add to Watchlist

24.58 -0.11 -0.45%

21:00:29 - Closed. Currency in USD ( Disclaimer )

After Hours

24.58

0.00

0.00%

22:04:36 - Real-time Data

Volume: 267,041
Bid/Ask: 20.00 / 25.64
Day's Range: 24.55 - 25.50

Type: Equity

Market: United States

BCYC Balance Sheet

Assess the latest Bicycle Therapeutics Ltd balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced BCYC Annual Report data, financial summaries and charts are available for Bicycle Therapeutics Ltd investors with their own InvestingPro account.

Annual Quarterly

Advanced Balance Sheet

Collapse All

Period Ending:

2024

31/03

2023

31/12

2023

30/09

2023

30/06

Total Current Assets

515.96

561.87

603.04

408.43

Cash and Short Term Investments	457	526.42	572.09	340.43
Cash	-	-	-	-
Cash & Equivalents	457	526.42	572.09	340.43
Short Term Investments	-	-	-	-
Total Receivables, Net	39.06	24.04	17.28	57.97
Accounts Receivables - Trade, Net	-	-	-	45.09
Total Inventory	-	-	-	-
Prepaid Expenses	19.9	11.41	13.67	10.02
Other Current Assets, Total	-	-	-	-

Total Assets

547.14

595.34

638.68

454.17

Property/Plant/Equipment, Total - Net	24.81	27.68	30.2	33.59
Property/Plant/Equipment, Total - Gross	-	41.08	41.59	44.04
Accumulated Depreciation, Total	-	-13.39	-11.4	-10.44
Goodwill, Net	-	-	-	-
Intangibles, Net	-	-	-	-
Long Term Investments	-	-	-	-
Note Receivable - Long Term	39.06	24.04	17.28	12.88
Other Long Term Assets, Total	6.37	5.79	5.45	12.15
Other Assets, Total	-39.06	-24.04	-17.28	-57.97

Total Current Liabilities

49.51

69.54

69.74

72.27

Accounts Payable	7.06	13.05	8.49	5.25
Payable/Accrued	-	-	-	-
Accrued Expenses	26.03	26.38	29.09	29.67
Notes Payable/Short Term Debt	-	-	-	-
Current Port. of LT Debt/Capital Leases	-	4.88	4.66	4.68
Other Current liabilities, Total	16.42	25.24	27.49	32.66

Total Liabilities

191.1

224.41

222.66

234.07

Total Long Term Debt	30.8	30.7	30.6	30.51
Long Term Debt	30.8	30.7	30.6	30.51
Capital Lease Obligations	-	-	-	-
Deferred Income Tax	-	-	-	-
Minority Interest	-	-	-	-
Other Liabilities, Total	110.78	124.18	91.72	100.78

Total Equity

356.05

370.93

416.02

220.1

Redeemable Preferred Stock, Total	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-
Common Stock, Total	0.553	0.55	0.55	0.396
Additional Paid-In Capital	894.6	883.45	875.25	633.34
Retained Earnings (Accumulated Deficit)	-538.32	-511.76	-462.66	-412.76
Treasury Stock - Common	-	-	-	-
ESOP Debt Guarantee	-	-	-	-
Unrealized Gain (Loss)	-	-	-	-
Other Equity, Total	-0.778	-1.3	2.88	-0.877

Total Liabilities & Shareholders' Equity

547.14

595.34

638.68

454.17

Total Common Shares Outstanding

42.56

37.73

37.68

30.59

Total Preferred Shares Outstanding

* In Millions of USD (except for per share items)

Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

I Agree

BCYC Price Commentary

Write your thoughts about Bicycle Therapeutics Ltd

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Alessandro Gallazzi Feb 05, 2020 18:20

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

New cancer drugs, first on their kind. Bicycle will soon launch a number of new treatments that will target very specifically the tumure. Compare to monoclonal antibodies treatments their patented production process is simple and cheap.

2 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="208883628">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="208883628" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="208883628" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="208883628">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

FTSE 100	8,213.49	+41.34	+0.51%
DAX	17,993.69	+97.19	+0.54%
Euro Stoxx 50	4,920.95	+30.60	+0.63%
S&P 500	5,127.79	+63.59	+1.26%
Nikkei 225	38,236.07	-37.98	-0.10%
Dow Jones	38,675.68	+450.02	+1.18%
FTSE 100 Futures	8,256.4	+48.5	+0.59%

Brent Oil	82.84	-0.83	-0.99%
Crude Oil WTI	77.99	-0.96	-1.22%
Gold	2,310.10	+0.50	+0.02%
Silver	26.790	-0.039	-0.15%
Copper	4.5680	+0.0835	+1.86%
London Cocoa	7,461.00	+317.00	+4.44%
London Wheat	181.75	+1.85	+1.03%

U.K. 10Y	4.2600	+0.0330	+0.78%
U.K. 5Y	4.1315	+0.0265	+0.65%
U.K. 2Y	4.3860	+0.0260	+0.60%
Germany 10Y	2.4910	-0.0190	-0.76%
U.S. 10Y	4.497	-0.074	-1.61%
U.S. 5Y	4.482	-0.085	-1.87%
U.S. 2Y	4.806	-0.071	-1.46%

Lloyds Banking	52.18	+0.12	+0.23%
Vodafone Group PLC	68.440	+0.620	+0.91%
Barclays	202.35	+1.35	+0.67%
BT Group	105.10	+1.55	+1.50%
HSBC	705.50	+0.50	+0.07%
BHP Group Ltd	2,241.00	+9.00	+0.40%
Exxon Mobil	116.02	-0.22	-0.19%

Recent Quotes

	Name	Price	Chg.	Chg. %
	BCYC	24.58	-0.11	-0.45%

Market Movers

Name	Last	Chg. %	Vol.
BP	510.40	-1.05%	26.15M
Glencore	455.00	-0.81%	25.91M
HSBC	705.50	+0.07%	16.83M
Shell	2,858.5	-0.51%	5.51M
Anglo American	2,693.5	+1.20%	5.18M
Reckitt Benckiser	4,476.0	+0.16%	3.32M
AstraZeneca	12,050.0	-0.87%	1.64M

Name	Last	Chg. %	Vol.
Verastem	10.77	+100000.00%	0.18K
Edgio	9.86	+100000.00%	0.40K
Future Fintech	0.87	+100000.00%	0.06K
UIE PLC	221.50	+100000.00%	1.27K
Romande Energie Holding SA	58.40	+100000.00%	0.00K
MFE MEDIAFOREUROPE NV B	3.748	+210.01%	9.55K
Frontline	267.10	+135.75%	4.60K

Name	Last	Chg. %	Vol.
H Lundbeck B	33.46	-80.74%	4.26K
BioGaia B	114.00	-77.89%	0.28K
Hydrogen Refueling	5.25	-64.33%	0.04K
Tomra Systems	142.70	-58.96%	21.34K
Atlas Copco B	167.80	-55.59%	3.33M
Remark	0.12	-55.56%	4.22K
Electrolux B	95.98	-52.48%	401.00K